Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional study.
JAAD Int
; 5: 112-120, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34712997
ICI, immune checkpoint inhibitor; OR, odds ratio; OS, overall survival; PD-1, programmed cell death-1; PFS, progression-free survival; aHR, adjusted hazard ratio; checkpoint inhibitors; halo phenomenon around cutaneous metastases; immunotherapy; irAE, immune-related adverse event; leukotrichia; melanoma; vitiligo
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
JAAD Int
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: